The Biden administration had said in recent days that it wanted to begin offering boosts to the general public as early as this week, pending permission from U.S. regulators.
The Food and Drug Administration has authorized the vaccination with a third boost of the Pfizer and BioNTech vaccine for Covid-19 for people 65 years of age and older and vulnerable groups.
The FDA decision comes after an 8-hour meeting of the Agency in the previous days, where a group of external experts discussed and voted on the implementation of the Pfizer vaccine to offer boosting doses to the general public.
The Advisory Committee on Vaccines and Related Biological Products voted 16-2 against the distribution of vaccines to Americans 16 years of age and older before unanimously adopting an alternative third-dose plan for older Americans and those at high risk. from serious diseases if infected with the coronavirus.
The Biden administration had said in recent days that it wanted to begin offering boosts to the general public as early as this week, pending permission from U.S. regulators.
In documents released last week, Pfizer cited an observational study in Israel that showed that a third dose of the Covid-19 vaccine six months after the second dose restored 95% protection against infection. Data were collected from July 1 to August 30, when the rapid spread of the Delta mutation increased across the country.
source: TO THEMA ONLINE
